Physician profile
James Harrington
NPI 1043204290
$3,622.01
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $431 · 2021: $933 · 2022: $809 · 2023: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,247.66 | 2019-2023 | Actifuse |
| Nuvasive, INC. | $652.33 | 2019-2022 | |
| Spineology INC. | $641.09 | 2019-2021 | |
| Relievant Medsystems, INC. | $313.45 | 2021-2023 | Intracept |
| Depuy Synthes Sales INC. | $210.29 | 2019-2020 | |
| Medtronic USA, INC. | $202.68 | 2019-2020 | |
| Medtronic, INC. | $145.19 | 2022-2023 | Mazor X System |
| Boston Scientific Corporation | $69.63 | 2022-2023 | |
| Si-Bone, INC. | $37.12 | 2022 | |
| Eisai INC. | $35.13 | 2021 | |
| Precision Spine, INC. | $25.24 | 2023 | |
| Nevro Corp. | $23.01 | 2023 | Senza |
| Zimmer Biomet Holdings, INC. | $19.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.